IP Library Patent Application 16874218
Patent Application
App. No. 16/874,218

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/874,218
Abstract

This invention provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering to a patient in need a guanylate cyclase receptor agonist (GCRA) peptide. Compositions comprising guanylate cyclase receptor agonist (GCRA) peptides, methods of making, and methods of treatment are also disclosed.

Claims (14)

1 . (canceled)

2 . A method of treating opioid induced constipation in a subject,

the method comprising administering to the subject a composition comprising a guanylate receptor agonist (GCRA) peptide of amino acid sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 9, and administering to the subject a composition comprising methylnaltrexone.

3 . The method of claim 2 , wherein the GCRA peptide has the amino acid sequence of SEQ ID NO: 1.

4 . The method of claim 2 , wherein the GCRA peptide has the amino acid sequence of SEQ ID NO: 9.

5 . The method of claim 2 , wherein the method further comprises administering an opioid to the subject.

6 . The method of claim 5 , wherein the opioid is selected from the group consisting of morphine, methadone, codeine, oxycodone, hydrocodone, dihydrocodeine, propoxyphene, fentanyl, tramadol, loperamide, butorphanol, and any combination thereof.

7 . The method of claim 5 , wherein the opioid is morphine or methadone.

8 . A method of treating opioid induced constipation in a subject being treated with an opioid,

the method comprising administering to the subject a composition comprising a guanylate receptor agonist (GCRA) peptide selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 9, and administering to the subject a composition comprising methylnaltrexone;

wherein the opioid is selected from the group consisting of morphine, methadone, codeine, oxycodone, hydrocodone, dihydrocodeine, propoxyphene, fentanyl, tramadol, loperamide, butorphanol, and any combination thereof.

9 . The method of claim 8 , wherein the GCRA peptide has the amino acid sequence of SEQ ID NO: 1.

10 . The method of claim 8 , wherein the GCRA peptide has the amino acid sequence of SEQ ID NO: 9.

11 . The method of claim 8 , wherein the opioid is methadone or morphine.

Assignments (1)
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →